Both in Pharmaceuticals
Harmony Biosciences Holdings vs Trevi Therapeutics
Over the past year HRMY returned +12.0% and TRVI returned +28.8%; their daily moves had a correlation of 0.21.
HRMY +12.0% TRVI +28.8%Growth of $1, one year, split-adjusted
| Metric | HRMY | TRVI |
|---|---|---|
| Price | $34.42 | $13.99 |
| Market cap | $2.00B | $1.99B |
| Today | −7.04% | +0.90% |
| 1 month | −12.6% | +6.1% |
| 6 months | +5.0% | −1.9% |
| Year to date | −8.0% | +11.7% |
| 1 year | +17.3% | +30.7% |
| Revenue growth (YoY) | +30.3% | — |
| Gross margin | 75.8% | — |
| Net margin | 28.9% | — |
| P/E (TTM) | 11.1× | — |
| Price / sales | 2.1× | — |
| Net cash | $513.8M | $318.9M |
| Dividend yield | — | — |
| Volatility (60d) | 35.9% | 39.4% |
| Short % of float | 11.8% | 14.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).